Tuesday, February 2, 2016

Making the leap from sequence data to actionable targets in clinical oncology

The ever-shrinking cost of DNA sequencing improves accessibility for an increasing number of people and, importantly, for the diagnosis and treatment of disease. This is particularly salient in cancer genetics, as cancer is often the result of mutation in not one gene, but many. Moreover, personalized genomics is the foundation of precision medicine; however, having the DNA sequence in hand is only half of the equation.



from Top Health News – ScienceDaily http://bit.ly/20m7jUd via Naturally Increase Breast Size At Home
from Tumblr http://bit.ly/1VGizEc

No comments:

Post a Comment